Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Naive Infants

A Phase I/II observer-blind, randomized, controlled trial evaluated the safety and immunogenicity of a dengue virus (DENV) vaccine candidate in healthy Thai infants (aged 12–15 months) without measurable pre-vaccination neutralizing antibodies to DENV and Japanese encephalitis virus. Fifty-one subje...

詳細記述

保存先:
書誌詳細
主要な著者: Watanaveeradej, Veerachai, Simasathien, Sriluck, Nisalak, Ananda, Endy, Timothy P., Jarman, Richard G., Innis, Bruce L., Thomas, Stephen J., Gibbons, Robert V., Hengprasert, Sumetha, Samakoses, Rudiwilai, Kerdpanich, Angkool, Vaughn, David W., Putnak, J. Robert, Eckels, Kenneth H., Barrera, Rafael De La, Mammen, Mammen P.
フォーマット: Artigo
言語:Inglês
出版事項: The American Society of Tropical Medicine and Hygiene 2011
主題:
Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC3144835/
https://ncbi.nlm.nih.gov/pubmed/21813857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.2011.10-0501
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料